Clinical Trial Update: PPI Refractory - GERD Mechanisms in Systemic Sclerosis

View source ↗

Summary

The trial investigates mechanisms of proton pump inhibitor-refractory gastroesophageal reflux disease in systemic sclerosis and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Systemic Sclerosis

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Systemic Sclerosis (SSc), GERD (Gastroesophageal Reflux Disease) | Status: NOT_YET_RECRUITING